Skip to content
中文产业新闻精选评分66Chinese source

默沙东引进思璞锐KRAS G12D(ON)抑制剂SPR2015,首付4亿美元总价21.3亿美元并申报IND

思璞锐:KRAS G12D(ON)抑制剂申报IND

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.